Induced Vaginal Delivery Clinical Trial
Official title:
Mifepristone as an Adjunct to Transcervical Balloon for Labor Induction (MiLI): A Randomized Clinical Trial
The purpose of this trial is to explore mifepristone as an option for induction of labor at term by evaluating the efficacy of mifepristone use for cervical preparation. Since the Labor Induction versus Expectant Management in Low-Risk Nulliparous Women (ARRIVE) trial supporting that elective induction after 39 weeks decreases cesarean sections and morbidity, rates of elective term inductions are increasing. At Lucile Packard Children's Hospital at Stanford University specifically, approximately 40% of spontaneous vaginal deliveries follow induction of labor, with an average induction time of 20 hours. Previous studies have established the maternal and neonatal safety of mifepristone in term inductions, however, this study will assess the difference in overall time from induction to complete cervical dilation, delivery, and the total time on Labor and Delivery.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05981469 -
Can Cervical Stiffness Predict Successful Vaginal Delivery After Induction of Labour?
|
||
| Recruiting |
NCT05798728 -
Outpatient Transcervical Balloon For Induction of Labor
|
N/A | |
| Not yet recruiting |
NCT04416022 -
Cervical Gland Area as a Predictor of Success of Labour Induction
|
||
| Active, not recruiting |
NCT05404776 -
Tension Versus Tension- Free Foley Balloon for Cervical Ripening
|
N/A | |
| Completed |
NCT06339528 -
Potential of Vojta's Reflex Locomotion as a Pre/Induction Method for Uterine Activity: a Pilot Study
|
N/A | |
| Completed |
NCT05424445 -
MISOBEST - Orally Misoprostol Solution (Cytotec®) Versus Orally Misoprostol as a Tablet (Angusta®) for Induction of Labor
|
Phase 3 | |
| Completed |
NCT03629548 -
Comparing Foley Catheter Balloon With Early Amniotomy for Induction of Labor at Term
|
N/A |